StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by Jonnyboy85on Jan 06, 2021 11:53am

118 Views

Post# 32233306

Industrial Alliance Securities Inc. ;)

IAS, a wholly owned subsidiary of Industrial Alliance Insurance and Financial Services Inc.

Industrial Alliance Securities inc. (IAS) is a wholly owned subsidiary of Industrial Alliance Insurance and Financial Services inc. Our parent company is listed on the Toronto Stock Exchange under the ticker symbol IAG and manages assets of over 112.9 billion dollars. The value of shares in circulation is over 4.3 billion dollars. Its growth and financial strength make it one of the largest public companies in Canada.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing